CP
HAE icon

CenterBook Partners’s Haemonetics HAE Stock Holding History

CenterBook Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,650
Closed -$324K – 607
2025
Q3 		$324K Buy
+6,650
New +$412K 0.02% 526
2023
Q2 		– Sell
-6,167
Closed -$510K – 443
2023
Q1 		$510K Buy
6,167
+810
+15% +$65.6K 0.07% 309
2022
Q4 		$421K Buy
+5,357
New +$431K 0.07% 303

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CenterBook Partners's HAE Position: Q4 2025 in Review

CenterBook Partners sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 6,650 shares — an estimated $324K sold.

CenterBook Partners first reported a position in HAE in Q4 2022 and held it in 3 quarters. The position peaked at $510K in Q1 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • CenterBook Partners reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • CenterBook Partners sold 6,650 Haemonetics shares in Q4 2025, an estimated $324K.
  • CenterBook Partners first reported a position in Haemonetics in Q4 2022 and held it in 3 quarters.
  • CenterBook Partners's Haemonetics position peaked at $510K in Q1 2023.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on CenterBook Partners's 13F filing for Q4 2025, filed 11 Feb 2026.